Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04726332
Status:
TERMINATED
Last Update Posted:
2024-05-14
First Post:
2021-01-22
Brief Title:
Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors QUARTZ-101
Sponsor:
Exelixis
Organization:
Exelixis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoplasm Malignant |
| Epithelial Ovarian Cancer |
| Triple Negative Breast Cancer |
| Hormone Receptor Positive Breast Carcinoma |
| Metastatic Castration-resistant Prostate Cancer |
Keywords:
| Name | View |
|---|---|
| cdk7 inhibitor | View |